Metraipolis › archive › dc_c93afe34f0eb
Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41446458
- DOI
- 10.7759/cureus.97530
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T08:11:00.866Z
- SHA-256 of the archived text
b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2- Stable URL of this page
https://metraipolis.com/documento/dc_c93afe34f0eb
How to cite
Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458 — Europe PMC (en), https://europepmc.org/article/MED/41446458 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c93afe34f0eb (Metraipolis archive dc_c93afe34f0eb, sha256 b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2)
BibTeX
@misc{dcc93afe34f0eb,
title = {Successful Treatment of Nivolumab Plus Ipilimumab After Progression on Durvalumab Plus Tremelimumab in Advanced Hepatocellular Carcinoma: A Case Report — Europe PMC PMID:41446458},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41446458},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c93afe34f0eb; sha256 b94f54bb3b36476e41c17ea960d52fa5f7b5a7125bf9257e3f370b44a6d82dd2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446458. Agents can read the archived copy with the MCP tool read_document.